Journalist Briefing

For health reporters, science journalists, and policy researchers covering kratom, 7-OH, and retail-access substances.

What This Page Is

This is a briefing document — not a product page. It is offered as a resource for journalists covering the DEA rulemaking on 7-hydroxymitragynine, the broader retail pharmacology story, or the clinical picture that the current data infrastructure is missing.

If you are covering this space and want a practitioner source who has named and documented the treatment gap, contact information is at the bottom.

What Appears to Be Changing

Across a range of substances now available through retail channels — particularly high-potency kratom extracts and 7-hydroxymitragynine products — a consistent pattern is emerging.

Use is becoming more frequent. Intervals between doses are shortening. Escalation appears to occur more quickly than expected.

Individuals attempting to stop or reduce use often describe a similar experience: repeated attempts that initially appear manageable but become increasingly difficult to sustain. Periods of relative stability are followed by abrupt destabilization, even when the overall trajectory is downward.

These reports are not confined to a single setting. They appear across online communities, anecdotal accounts, and direct observation in intake settings over more than two decades. While not yet systematically studied at scale, the pattern itself is consistent enough to warrant closer attention.

‍ ‍

A Shift in the Environment

One possible explanation lies not only in the substances themselves, but in how they are now distributed and consumed.

Products that were once difficult to access are now widely available in retail environments, packaged for convenience and rapid onset, and used in shorter, more frequent cycles.

This creates a different exposure pattern than traditional models of use. Instead of longer intervals and slower accumulation, individuals are often engaging with substances in rapid, repeated sequences. The result is not simply more use, but a change in how use unfolds over time.

Compression of Intervals

A defining feature of these patterns is interval compression — the shortening of time between uses.

As intervals compress, the system has less time to return to baseline, reinforcement becomes more frequent, and small changes in use can produce larger-than-expected effects. This can create a dynamic where stability becomes harder to maintain. Attempts to reduce may be interrupted not by external factors, but by internal variability — fluctuations in sleep, mood, and physical state that make consistency difficult.

A Kindling-Like Dynamic

One way to interpret this pattern is through a kindling-like mechanism. In neuroscience, kindling refers to a process in which repeated stimulation lowers the threshold for future response. Over time, less input is required to produce the same or greater effect.

Applied here, repeated exposure in compressed intervals may increase sensitivity to both use and absence of use, amplify fluctuations between states, and accelerate the transition from controlled to unstable patterns.

In a retail environment where access is immediate and repetition is easy, this dynamic may be intensified.

Why Existing Models May Not Fully Explain It

Traditional models of substance use and withdrawal were largely developed in contexts with different patterns of exposure — longer intervals, slower onset, and more constrained access. Those models remain valid in many settings. However, they may not fully capture what happens when onset is rapid, access is continuous, and intervals between exposures are short.

Under these conditions, instability may emerge earlier and progress more quickly than expected. Standard clinical assessment instruments — including COWS-based induction protocols — were calibrated for a different patient and a different withdrawal arc.

The Clinical Gap

The population currently caught in compressed-cycle 7-OH dependence is largely invisible to the data infrastructure that moves institutions to act. They are functional, employed, and not presenting in emergency departments. They are not in the overdose statistics.

They are awake at 3am managing a withdrawal arc that closes in two to three hours — not twelve to twenty-four — reaching for something that looks like a nicotine vape and works like an opioid.

The clinical frameworks for understanding this population — including the withdrawal presentation, the induction timing problem, and the post-exit recovery arc — are documented in full at Pivot Protocols.

Further Reading

The Rise of Retail Pharmacology
A short overview of emerging patterns associated with rapid-access substances, including interval compression and kindling-like dynamics.

Compressed-Cycle Opioid Dependence
A description of accelerated use patterns observed in short-interval opioid exposure.

For Clinicians and Researchers
Additional context translating these observations into established clinical terminology.

Contact

John Leonard is the founder of Pivot Protocols and a recovery program leader with 23 years of front-line experience, including twelve years as Founder and CEO of Redemption House and as Director of Marketing and Intake at The Retreat in Wayzata, Minnesota. He is available as a practitioner source for journalists covering this space.

651-270-2358
john@pivotprotocols.com pivotprotocols.com

Pivot Protocols is a behavioral consulting practice and does not provide medical, clinical, or mental health services. The frameworks on this site are offered for educational and pattern-recognition purposes.